“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Michael B. Petras, Jr. net worth and biography

Michael Petras, Jr. Biography and Net Worth

CEO of Sotera Health

Michael Petras has served as our Chief Executive Officer since June 2016, as the Chairman of our board since January 2019 and as a member of our board since June 2016. Prior to joining Sotera Health, Mr. Petras served as chief executive officer of Post-Acute Solutions at Cardinal Health, Inc., a multinational healthcare services company, from 2015 to 2016 and chief executive officer of Cardinal Health at-Home at Cardinal Health, Inc. from 2013 to 2015. From 2011 to 2013, he was the chief executive officer for AssuraMed Holdings, Inc., a medical products supplier owned by the Clayton, Dubilier & Rice and Goldman Sachs private equity firms, which was sold to Cardinal Health, Inc. in 2013. From 2008 to 2011, Mr. Petras was president and chief executive officer at GE Lighting, a General Electric Company (“GE”) business unit. During his over 20 year career at GE, he held several management positions in multiple disciplines. Mr. Petras holds a B.S.B.A. in finance from John Carroll University and an M.B.A. in marketing from Case Western Reserve University.

How do I contact Michael B. Petras, Jr.?: The corporate mailing address for Mr. Petras, Jr. and other Sotera Health executives is 9100 SOUTH HILLS BLVD SUITE 300, BROADVIEW HEIGHTS OH, 44147. Sotera Health can also be reached via phone at 440-262-1410 and via email at [email protected]. Learn More on Michael B. Petras, Jr.'s contact information.
Has Michael B. Petras, Jr. been buying or selling shares of Sotera Health?: Michael B. Petras, Jr. has not been actively trading shares of Sotera Health during the past quarter. Learn More on Michael B. Petras, Jr.'s trading history.
Who are Sotera Health's active insiders?: Sotera Health's insider roster includes Michael Petras, Jr. (CEO), and Michael Rutz (Insider). Learn More on Sotera Health's active insiders.
Are insiders buying or selling shares of Sotera Health?: In the last twelve months, insiders at the sold shares 3 times. They sold a total of 26,677,472 shares worth more than $388,954,624.32. The most recent insider tranaction occured on September, 6th when Director Gtcr Investment Xi Llc sold 10,000,000 shares worth more than $150,300,000.00. Insiders at Sotera Health own 55.1% of the company. Learn More about insider trades at Sotera Health.
Information on this page was last updated on 9/6/2024.

Michael B. Petras, Jr. Insider Trading History at Sotera Health

Michael B. Petras, Jr. Buying and Selling Activity at Sotera Health

Sotera Health Company Overview

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Today's Range

Now: $12.82

$12.40

$12.97

50 Day Range

MA: $15.61

$12.41

$16.91

2 Week Range

Now: $12.82

$10.71

$17.44

Volume

4,168,639 shs

Average Volume

1,326,370 shs

Market Capitalization

$3.63 billion

P/E Ratio

51.28

Dividend Yield

N/A

Beta

2.08